Recombinant multi-species HNRNPA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HNRNPA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of a family of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs), which are RNA-binding proteins that associate with pre-mRNAs in the nucleus and influence pre-mRNA processing, as well as other aspects of mRNA metabolism and transport. The protein encoded by this gene is one of the most abundant core proteins of hnRNP complexes and plays a key role in the regulation of alternative splicing. Mutations in this gene have been observed in individuals with amyotrophic lateral sclerosis 20. Multiple alternatively spliced transcript variants have been found. There are numerous pseudogenes of this gene distributed throughout the genome. [provided by RefSeq, Feb 2016]
The Alternative Names of target: ALS19,ALS20,HCP-1,HDP-1,HNRNPA1,HNRPA1,HNRPA1L3,Hdp,Helix-destabilizing protein,Heterogeneous nuclear ribonucleoprotein A1,Hnrnpa1,Hnrpa1,IBMPFD3,MPD3,Single-strand RNA-binding protein,UP 1,hnRNP A1,hnRNP core protein A1,hnRNP-A1,hnrnp-A1

Target products collectionGo to HNRNPA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7973-Ag-1/ GM-Tg-hg-IP7973-Ag-2 Human HNRNPA1 protein Human
GM-Tg-rg-IP7973-Ag-1/ GM-Tg-rg-IP7973-Ag-2 Rat HNRNPA1 protein Rat
GM-Tg-mg-IP7973-Ag-1/ GM-Tg-mg-IP7973-Ag-2 Mouse HNRNPA1 protein Mouse
GM-Tg-cynog-IP7973-Ag-1/ GM-Tg-cynog-IP7973-Ag-2 Cynomolgus/Rhesus macaque HNRNPA1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7973-Ag-1/ GM-Tg-felg-IP7973-Ag-2 Feline HNRNPA1 protein Feline
GM-Tg-cang-IP7973-Ag-1/ GM-Tg-cang-IP7973-Ag-2 Canine HNRNPA1 protein Canine
GM-Tg-bovg-IP7973-Ag-1/ GM-Tg-bovg-IP7973-Ag-2 Bovine HNRNPA1 protein Bovine
GM-Tg-equg-IP7973-Ag-1/ GM-Tg-equg-IP7973-Ag-2 Equine HNRNPA1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7973-Ag-1/ GM-Tg-hg-IP7973-Ag-2; GM-Tg-rg-IP7973-Ag-1/ GM-Tg-rg-IP7973-Ag-2;
GM-Tg-mg-IP7973-Ag-1/ GM-Tg-mg-IP7973-Ag-2; GM-Tg-cynog-IP7973-Ag-1/ GM-Tg-cynog-IP7973-Ag-2;
GM-Tg-felg-IP7973-Ag-1/ GM-Tg-felg-IP7973-Ag-2; GM-Tg-cang-IP7973-Ag-1/ GM-Tg-cang-IP7973-Ag-2;
GM-Tg-bovg-IP7973-Ag-1/ GM-Tg-bovg-IP7973-Ag-2; GM-Tg-equg-IP7973-Ag-1/ GM-Tg-equg-IP7973-Ag-2
Products Name HNRNPA1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name HNRNPA1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HNRNPA1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.